Cargando…
A Fungal Defensin Targets the SARS−CoV−2 Spike Receptor−Binding Domain
Coronavirus Disease 2019 (COVID−19) elicited by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS−CoV−2) is calling for novel targeted drugs. Since the viral entry into host cells depends on specific interactions between the receptor−binding domain (RBD) of the viral Spike protein and the me...
Autores principales: | Gao, Bin, Zhu, Shunyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304516/ https://www.ncbi.nlm.nih.gov/pubmed/34356932 http://dx.doi.org/10.3390/jof7070553 |
Ejemplares similares
-
Enhancement of SARS-CoV-2 receptor-binding domain activity by two microbial defensins
por: Gao, Bin, et al.
Publicado: (2023) -
The Fungal Defensin Family Enlarged
por: Wu, Jiajia, et al.
Publicado: (2014) -
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
por: Hussain, Arif, et al.
Publicado: (2020) -
Small Molecules
Targeting SARS-CoV-2 Spike
Glycoprotein Receptor-Binding Domain
por: Rodríguez, Yoel, et al.
Publicado: (2022) -
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Chi, Xiaojing, et al.
Publicado: (2020)